AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN: 2,450 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
2,450
Total FAERS Reports
344 (14.0%)
Deaths Reported
518
Hospitalizations
2,450
As Primary/Secondary Suspect
126
Life-Threatening
70
Disabilities
Active Ingredient: AMLODIPINE BESYLATE\HYDROCHLOROTHIAZIDE\VALSARTAN ·
First Report: 1988 · Latest Report: 20250722
What Are the Most Common AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN Side Effects?
#1 Most Reported
Blood pressure increased
306 reports (12.5%)
#2 Most Reported
Wrong technique in product usage process
222 reports (9.1%)
#3 Most Reported
Death
199 reports (8.1%)
All AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Blood pressure increased | 306 | 12.5% | 3 | 74 |
| Wrong technique in product usage process | 222 | 9.1% | 12 | 46 |
| Death | 199 | 8.1% | 199 | 7 |
| Hypertension | 170 | 6.9% | 9 | 32 |
| Diabetes mellitus | 167 | 6.8% | 5 | 22 |
| Off label use | 162 | 6.6% | 14 | 32 |
| Malaise | 161 | 6.6% | 3 | 41 |
| Drug ineffective | 144 | 5.9% | 3 | 26 |
| Blood pressure decreased | 139 | 5.7% | 1 | 34 |
| Dizziness | 119 | 4.9% | 0 | 31 |
| Headache | 115 | 4.7% | 1 | 14 |
| Feeling abnormal | 113 | 4.6% | 3 | 21 |
| Peripheral swelling | 113 | 4.6% | 0 | 17 |
| Deafness | 97 | 4.0% | 1 | 1 |
| Cerebrovascular accident | 96 | 3.9% | 7 | 21 |
| Fall | 90 | 3.7% | 5 | 31 |
| Visual impairment | 90 | 3.7% | 0 | 15 |
| Gait disturbance | 86 | 3.5% | 1 | 15 |
| Fatigue | 78 | 3.2% | 1 | 15 |
| Infarction | 76 | 3.1% | 15 | 26 |
Who Reports AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN Side Effects? Age & Gender Data
Gender: 60.1% female, 39.9% male. Average age: 67.2 years. Most reports from: COUNTRY NOT SPECIFIED. View detailed demographics →
Is AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2005 | 2 | 0 | 0 |
| 2006 | 1 | 0 | 0 |
| 2007 | 3 | 0 | 0 |
| 2008 | 3 | 0 | 1 |
| 2009 | 1 | 0 | 0 |
| 2010 | 3 | 0 | 2 |
| 2011 | 9 | 2 | 2 |
| 2012 | 22 | 2 | 7 |
| 2013 | 45 | 4 | 8 |
| 2014 | 76 | 8 | 33 |
| 2015 | 79 | 8 | 17 |
| 2016 | 77 | 8 | 23 |
| 2017 | 83 | 16 | 16 |
| 2018 | 101 | 11 | 28 |
| 2019 | 95 | 13 | 28 |
| 2020 | 134 | 41 | 46 |
| 2021 | 139 | 16 | 27 |
| 2022 | 91 | 10 | 26 |
| 2023 | 77 | 9 | 23 |
| 2024 | 31 | 0 | 11 |
| 2025 | 13 | 0 | 6 |
What Is AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN Used For?
| Indication | Reports |
|---|---|
| Hypertension | 1,297 |
| Product used for unknown indication | 877 |
| Blood pressure increased | 91 |
| Blood pressure abnormal | 63 |
| Cardiac disorder | 28 |
| Blood pressure measurement | 25 |
| Essential hypertension | 11 |
| Diabetes mellitus | 8 |
| Coronary artery disease | 6 |
| Foetal exposure during pregnancy | 6 |
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs Alternatives: Which Is Safer?
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\INDAPAMIDE\PERINDOPRIL
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\INDAPAMIDE\PERINDOPRIL ARGININE
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\OLMESARTAN MEDOXOMIL
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\PERINDOPRIL
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\PERINDOPRIL ARGININE
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\RAMIPRIL
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\TELMISARTAN
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMLODIPINE\VALSARTAN
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMMONIUM
AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN vs AMNESTEEM
Official FDA Label for AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN
Official prescribing information from the FDA-approved drug label.